Atara Biotherapeutics Inc (ATRA)

10:04 AM

How Atara Biotherapeutics Inc. stock reacts to global recession fearsJuly 2025 Opening Moves & Safe Entry Point Alerts - newser.com

10:04 AM

10:00 AM

How to use Fibonacci retracement on Atara Biotherapeutics Inc.Buy Signal & Fast Gain Swing Alerts - newser.com

10:00 AM

09:13 AM

Will Atara Biotherapeutics Inc. stock maintain growth storyMarket Risk Analysis & Consistent Return Strategy Ideas - newser.com

09:13 AM

04:52 AM

Volume spikes in Atara Biotherapeutics Inc. stock – what they meanMarket Sentiment Review & Weekly Hot Stock Watchlists - newser.com

04:52 AM

Oct 10, 2025

Can you recover from losses in Atara Biotherapeutics Inc.July 2025 Movers & Comprehensive Market Scan Insights - newser.com

Oct 10, 2025

Oct 10, 2025

Chart based exit strategy for Atara Biotherapeutics Inc.Market Activity Summary & Safe Investment Capital Preservation Plans - newser.com

Oct 10, 2025

Oct 10, 2025

Using economic indicators to assess Atara Biotherapeutics Inc. potentialJuly 2025 Selloffs & AI Forecast for Swing Trade Picks - newser.com

Oct 10, 2025

Oct 10, 2025

Will Atara Biotherapeutics Inc. continue its uptrendWeekly Risk Summary & Precise Buy Zone Tips - newser.com

Oct 10, 2025

Oct 10, 2025

What hedge fund activity signals for Atara Biotherapeutics Inc. stockJuly 2025 Volume & Capital Efficient Trading Techniques - newser.com

Oct 10, 2025

Oct 10, 2025

How rising interest rates impact Atara Biotherapeutics Inc. stockRisk Management & Free Technical Confirmation Trade Alerts - newser.com

Oct 10, 2025

Oct 09, 2025

Atara Biotherapeutics' (ATRA) "Sell (D+)" Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 09, 2025

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Stock Catapults 30% Though Its Price And Business Still Lag The Industry - simplywall.st

Oct 09, 2025

Oct 09, 2025

Atara Biotherapeutics Inc. stock trendline breakdownQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com

Oct 09, 2025

Oct 09, 2025

Statistical indicators supporting Atara Biotherapeutics Inc.’s strengthJuly 2025 Rallies & Verified Momentum Stock Ideas - newser.com

Oct 09, 2025

Oct 09, 2025

Pattern recognition hints at Atara Biotherapeutics Inc. upside2025 Momentum Check & Reliable Entry Point Trade Alerts - newser.com

Oct 09, 2025

Oct 07, 2025

Atara Biotherapeutics Inc Stock Analysis and ForecastAutomated Trading Signals & Your Free Entry to Smart Investing Starts Here - earlytimes.in

Oct 07, 2025

Oct 06, 2025

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Receives $21.00 Consensus Price Target from Brokerages - Defense World

Oct 06, 2025

Oct 06, 2025

How Atara Biotherapeutics Inc. (AT20) stock stacks up against competitorsNew Guidance & Real-Time Market Trend Scan - newser.com

Oct 06, 2025

Oct 06, 2025

Is Atara Biotherapeutics Inc. stock positioned for long term growthPortfolio Value Report & Expert Verified Stock Movement Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

What drives Atara Biotherapeutics Inc stock priceStock Price Divergence & Low Entry Capital Stocks - earlytimes.in

Oct 05, 2025

Oct 05, 2025

Can swing trading help recover from Atara Biotherapeutics Inc. losses2025 Top Decliners & Technical Entry and Exit Alerts - newser.com

Oct 05, 2025

Oct 03, 2025

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Oct 03, 2025

Oct 03, 2025

Pancreatic Cancer Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Dragonfly Therapeutics, Keymed B, Tango Therapeutics, Atara Bio, Keymed Biosciences, Carisma Therapeu - Barchart.com

Oct 03, 2025

Oct 03, 2025

While institutions own 28% of Atara Biotherapeutics, Inc. (NASDAQ:ATRA), individual investors are its largest shareholders with 35% ownership - Yahoo Finance

Oct 03, 2025

Oct 02, 2025

Cancer stocks rebound, outpacing broader markets in Q3 2025 - BioWorld MedTech

Oct 02, 2025

Oct 01, 2025

Analyzing net buyer seller activity in Atara Biotherapeutics Inc.Quarterly Investment Review & Reliable Volume Spike Alerts - newser.com

Oct 01, 2025

Sep 29, 2025

4 Biotechnology Stocks That Outshine In Momentum Amid Strong Technicals - inkl

Sep 29, 2025

Sep 29, 2025

Atara Biotherapeutics (ATRA) Reports Q4 Loss, Tops Revenue Estimates - MSN

Sep 29, 2025